The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine

被引：1
|
作者：
Naughton, M. [1 ]
Allen, A. P. [1 ,2 ]
Clarke, G. [1 ,2 ]
Dowling, J. [3 ]
Walsh, A. [3 ]
Ismail, F. [1 ]
Shorten, G. [3 ]
Scott, L. [1 ]
Cryan, J. F. [2 ,4 ]
Dinan, T. G. [1 ,2 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Dept Anaesthesia & Intens Care Med, Cork, Ireland
[4] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70639-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.b.038
引用
收藏
页码：S401 / S401
页数：1
相关论文
共 50 条
  • [41] Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
    Wan, Le-Ben
    Levitch, Cara F.
    Perez, Andrew M.
    Brallier, Jess W.
    Iosifescu, Dan V.
    Chang, Lee C.
    Foulkes, Alexandra
    Mathew, Sanjay J.
    Charney, Dennis S.
    Murrough, James W.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (03) : 247 - +
  • [42] Ketamine for treatment-resistant depression: recent developments and clinical applications
    Schwartz, Jaclyn
    Murrough, James W.
    Iosifescu, Dan V.
    EVIDENCE-BASED MENTAL HEALTH, 2016, 19 (02) : 35 - 38
  • [43] Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment-resistant depression
    Jesus-Nunes, Ana Paula
    Leal, Gustavo C.
    Correia-Melo, Fernanda S.
    Vieira, Flavia
    Mello, Rodrigo P.
    Caliman-Fontes, Ana Teresa
    Echegaray, Mariana V. F.
    Marback, Roberta F.
    Guerreiro-Costa, Livia N. F.
    Souza-Marques, Breno
    Santos-Lima, Cassio
    Souza, Lucca S.
    Bandeira, Igor D.
    Kapczinski, Flavio
    Lacerda, Acioly L. T.
    Quarantini, Lucas C.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2022, 37 (04)
  • [44] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (SUPPL 1) : 277 - 277
  • [45] Inflammation Moderates Antidepressant Response to Ketamine in a Rodent Model of Treatment-Resistant Depression: Bioenergetic and Inflammatory Markers of Response
    Tye, Susannah
    Price, J. Blair
    Walker, Adam
    Kruse, Jennifer
    Cullen, Kathryn
    Frye, Mark
    Schwieler, Lilly
    Erhardt, Sophie
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 : 277 - 277
  • [46] D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
    Moaddel, Ruin
    Luckenbaugh, David A.
    Xie, Ying
    Villasenor, Alma
    Brutsche, Nancy E.
    Machado-Vieira, Rodrigo
    Ramamoorthy, Anuradha
    Paz Lorenzo, Maria
    Garcia, Antonia
    Bernier, Michel
    Torjman, Marc C.
    Barbas, Coral
    Zarate, Carlos A., Jr.
    Wainer, Irving W.
    PSYCHOPHARMACOLOGY, 2015, 232 (02) : 399 - 409
  • [47] D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression
    Ruin Moaddel
    David A. Luckenbaugh
    Ying Xie
    Alma Villaseñor
    Nancy E. Brutsche
    Rodrigo Machado-Vieira
    Anuradha Ramamoorthy
    Maria Paz Lorenzo
    Antonia Garcia
    Michel Bernier
    Marc C. Torjman
    Coral Barbas
    Carlos A. Zarate
    Irving W. Wainer
    Psychopharmacology, 2015, 232 : 399 - 409
  • [48] RAPID RESPONSE TO LITHIUM IN TREATMENT-RESISTANT DEPRESSION
    JOYCE, PR
    HEWLAND, HR
    JONES, AV
    BRITISH JOURNAL OF PSYCHIATRY, 1983, 142 (FEB) : 204 - 206
  • [49] Clinical and genetic predictors of antidepressant response and remission in treatment-resistant depression
    Calati, R.
    Massat, I.
    Kasper, S.
    Montgomery, S.
    Zohar, J.
    Mendlewicz, J.
    Serretti, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S74 - S74
  • [50] Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol
    Martin, Josh
    Nezhad, Fatemeh Gholamali
    Rueda, Alice
    Lee, Gyu Hee
    Charlton, Colleen E.
    Soltanzadeh, Milad
    Ladha, Karim S.
    Krishnan, Sridhar
    Diaconescu, Andreea O.
    Bhat, Venkat
    PLOS ONE, 2024, 19 (08):
12345